피부흑색종

논문상세정보
    • 저자 이석종 이수정
    • 제어번호 105944296
    • 학술지명 대한의사협회지
    • 권호사항 Vol. 61 No. 11 [ 2018 ]
    • 발행처 대한의사협회
    • 자료유형 학술저널
    • 수록면 662-669
    • 언어 Korean
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 고려대학교 의학도서관
    • 판매처
    유사주제 논문( 0)
인용/피인용

' 피부흑색종' 의 참고문헌

  • Technical details of intra-operative lymphatic mapping for early stage melanoma
    Morton DL [1992]
  • Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan
    Saida T [2004]
  • Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma
  • Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
    Schachter J [2017]
  • Molecular biology of melanoma
    Swick JM [2012]
  • Melanoma staging: evidence-based changes in the American Joint Com-mittee on Cancer eighth edition cancer staging manual
  • Malig-nant melanoma: diagnostic and management update
  • Key point in dermoscopic differentiation between early nail apparatus melanoma and benign longitudinal melanonychia
    Koga H [2011]
  • Improved survival with vemurafenib in melanoma with BRAF V600E mutation
    Chapman PB [2011]
  • Improved survival with ipili-mumab in patients with metastatic melanoma
    Hodi FS [2010]
  • Determi-nation of the impact of melanoma surgical timing on survival using the National Cancer Database
    Conic RZ [2018]
  • Dermo-scopy report: proposal for standardization: results of a consen-sus meeting of the International Dermoscopy Society
    Malvehy J [2007]
  • Completion dissection or observation for sentinel-node metastasis in melanoma
    Faries MB [2017]
  • Combined nivolumab and ipi-limumab or monotherapy in untreated melanoma
    Larkin J [2015]
  • Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
    Flaherty KT [2012]
  • American Academy of Dermatology. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology